Branavan Manoranjan

Branavan Manoranjan serves as a Research Fellow within the Human Oncology and Pathogenesis Program at the Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center. He maintains affiliations with the Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center and Gerstner Sloan Kettering Graduate School of Biomedical Sciences.

His research centers on neuro-oncology and cancer metastasis mechanisms, with specialized focus on leptomeningeal metastasis – a severe complication where cancer spreads to the brain/spinal cord membranes. Current work investigates chemokine signaling pathways, particularly CXCL1's role in tumor growth within the central nervous system microenvironment.

Recent publication trends demonstrate concentrated expertise in metastatic oncology, with 2024 meeting abstracts examining molecular drivers of leptomeningeal disease progression. His work bridges neuro-oncology, tumor immunology, and metastasis biology.

Dr. Manoranjan collaborates within the Metastasis and Tumor Ecosystems Center framework, contributing to interdisciplinary research on tumor dissemination mechanisms through the Human Oncology and Pathogenesis Program.